Piximune Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1M

  • Investors
  • 5

Piximune General Information

Description

Operator of therapeutic biotechnology intended to treat retinal degenerative diseases and preserve vision. The company offers gene-agnostic antibodies focused on enhancing neuroprotective mechanisms within the retina, enabling patients with retinal disorders to access targeted treatments that support eye health and slow disease progression.

Contact Information

Website
www.piximune.com
Formerly Known As
BEX Vision
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 701 West Main Street
  • Suite 200
  • Durham, NC 27701
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 701 West Main Street
  • Suite 200
  • Durham, NC 27701
  • United States

Piximune Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Piximune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant $1M Completed Startup
5. Seed Round Completed Startup
4. Grant 30-Jun-2025 Completed Startup
3. Debt - General 09-Oct-2024 Completed Startup
2. Debt - General 31-May-2023 $250K $250K Completed Startup
1. University Spin-Out 08-Feb-2023 Completed Startup
To view Piximune’s complete valuation and funding history, request access »

Piximune Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Piximune Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
One North Carolina Fund Government
North Carolina Biotechnology Center Not-For-Profit Venture Capital
Duke University University
Retinal Degeneration Fund Not-For-Profit Venture Capital
To view Piximune’s complete investors history, request access »

Ready to get started?

Request a free trial

Piximune FAQs

  • When was Piximune founded?

    Piximune was founded in 2023.

  • Where is Piximune headquartered?

    Piximune is headquartered in Durham, NC.

  • What is the size of Piximune?

    Piximune has 2 total employees.

  • What industry is Piximune in?

    Piximune’s primary industry is Biotechnology.

  • Is Piximune a private or public company?

    Piximune is a Private company.

  • What is Piximune’s current revenue?

    The current revenue for Piximune is .

  • How much funding has Piximune raised over time?

    Piximune has raised $900K.

  • Who are Piximune’s investors?

    National Institutes of Health, One North Carolina Fund, North Carolina Biotechnology Center, Duke University, and Retinal Degeneration Fund have invested in Piximune.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process